Interventional Radiology Obesity Therapeutics: Proceedings from the Society of Interventional Radiology Foundation...

Area of Science:

• Interventional Radiology
• Obesity Therapeutics
• Bariatric Interventions

Background:

• A Research Consensus Panel convened experts to develop a research agenda for "Obesity Therapeutics" within interventional radiology (IR).
• The panel reviewed current obesity therapies and identified research gaps in IR bariatric interventions.
• Familiarization with the regulatory evaluation process for new therapies was also a key objective.

Discussion:

• Panelists reached a consensus that a weight loss exceeding 8%-10% from baseline at 6-12 months is a critical therapeutic endpoint for future IR weight loss strategies.
• The multidisciplinary group emphasized the need for high-quality research to advance the field of IR obesity therapeutics.
• Discussion focused on prioritizing research that addresses current deficiencies in IR bariatric interventions.

Key Insights:

• A desirable therapeutic endpoint for IR weight loss therapies was defined as >8%-10% weight reduction at 6-12 months.
• The highest priority research recommendation is a blinded randomized controlled trial comparing IR weight loss interventions against sham controls.
• Patient participation in behavioral therapy alongside IR interventions was a component of the proposed trial design.

Outlook:

• Future research should focus on rigorously evaluating IR bariatric interventions through blinded, randomized controlled trials.
• The development of effective IR weight loss therapies requires a clear understanding of therapeutic endpoints and robust clinical trial designs.
• Continued multidisciplinary collaboration is essential for advancing obesity therapeutics in interventional radiology.